Jinglong Chen
No ORCID on file
· 1 paper in corpus
BACKGROUND: Sorafenib is the standard targeted drug used to treat hepatocellular carcinoma (HCC), but the therapeutic response between individuals varies markedly. Recently, cytokine-based immunotherapy has been a topic of intense discussio…